BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, October 20, 2024
See today's BioWorld
Home
» Other news to note for June 29, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for June 29, 2021
June 29, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acrivon, Amgen, Antios, Applied Biomath, APR, Arbutus, Astrazeneca, Baymedica, Brigham and Women's Hospital, Cannex, Carmot, Cell and Gene Therapy Catapult, Compugen, Curie Institute, Defence, Diurnal, Elevatebio, E r-Kim, Etherna, Ichnos, Inmed, Innovent, Ixaka, KBI, Lilly, Mosaic Biosciences, Mosaic Immunoengineering, Ocular, Paratek, PYC, Q-State, Quantoom, Relief, Selexis, Simcere, Somalogic, Synaffix, Vivoryon.
BioWorld
Briefs
Other news to note
Coronavirus